98%
921
2 minutes
20
Huntington disease is associated with elongation of a CAG repeat in the HTT gene that results in a mutant huntingtin protein. Several studies have implicated N-terminal huntingtin protein fragments in Huntington disease pathogenesis. Ideally, these fragments are studied in human brain tissue. However, the use of human brain tissue comes with certain unavoidable variables such as post mortem delay, artefacts from freeze-thaw cycles and subject-to-subject variation. Knowledge on how these variables might affect N-terminal huntingtin protein fragments in post mortem human brain is important for a proper interpretation of study results. The effect of post mortem delay on protein in human brain is known to vary depending on the protein of interest. In the present study, we have assessed the effect of post mortem delay on N-terminal huntingtin protein fragments using western blot. We mimicked post mortem delay in one individual control case and one individual Huntington disease case with low initial post mortem delay. The influence of subject-to-subject variation on N-terminal huntingtin fragments was assessed in human cortex and human striatum using two cohorts of control and Huntington disease subjects. Our results show that effects of post mortem delay on N-terminal huntingtin protein fragments are minor in our individual subjects. Additionally, one freeze-thaw cycle decreases the huntingtin western blot signal intensity in the cortex control subject, but does not introduce additional N-terminal huntingtin fragments. Our results suggest that subject-to-subject variation contributes more to variability in N-terminal huntingtin fragments than post mortem delay.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453542 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178556 | PLOS |
ACS Chem Neurosci
September 2025
Fischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.
Nt17, the N-terminal domain of the huntingtin protein (htt), has garnered significant attention for its role in htt's membrane binding and aggregation processes. Previous studies have identified a nuclear export sequence within the Nt17 domain and demonstrated its localization at various cellular organelles. Recent evidence suggests that, like other amphipathic helices, Nt17 can sense and preferentially bind to curved membranes.
View Article and Find Full Text PDFBiochim Biophys Acta Mol Basis Dis
August 2025
CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, USA. Electronic address:
Huntington's disease is a neurodegenerative disorder associated with a polyglutamine expansion within the first exon of the huntingtin protein (HTT exon 1). This mutation results in HTT dysfunction and the production of N-terminal HTT aggregates. The dimerization of the HTT exon 1 fragment through self-association of the first 17 residues (N17) is considered the initial step in the HTT exon 1 aggregation pathway.
View Article and Find Full Text PDFMol Neurobiol
August 2025
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.
Huntington's disease (HD) is an inherited neurodegenerative condition that typically appears later in life, marked by progressive motor impairments, cognitive deterioration, and a range of psychiatric disturbances. Crucial to HD pathogenesis is the aberrant activation of caspase-6 (CASP6), which leads to the cleavage of mutant huntingtin (mHTT) protein, generating a toxic N-terminal fragment. CASP6 activity is elevated in human HD brains and is associated with the progression of neuropathology.
View Article and Find Full Text PDFJ Am Chem Soc
June 2025
Molecular Biophysics, Zernike Instituut, Rijksuniversiteit Groningen, 9747 AG Groningen, The Netherlands.
Amyloid fibril formation is a hallmark of various neurodegenerative diseases such as Huntington's (HD), Alzheimer's, and Parkinson's disease. The protein aggregation process involves slow nucleation events followed by rapid growth and elongation of formed fibrils. Understanding the pathways of amyloid formation is key to development of novel therapeutic agents that can interfere with the pathogenic protein misfolding events.
View Article and Find Full Text PDFBiophys Chem
October 2025
Department of Molecular Science and Technology, Ajou University, Suwon, Gyeonggi 16499, Republic of Korea; College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Gyeonggi 16499, Republic of Korea. Electronic address:
Huntington's disease (HD) is a genetic neurodegenerative disorder caused by the abnormal expansion of the polyglutamine (polyQ) tract (> 35Q) in the first exon of the huntingtin (Htt), HttEx1. This N-terminal fragment tends to form fibrillar inclusions, which constitute a key pathological hallmark of HD. Although polyQ expansion is commonly understood to be a primary cause of HttEx1 pathology, the molecular mechanism of aggregations of non-pathogenic polyQ tract with the N-terminally flanking region of N17 in HttEx1 (HttEx1-17Q) remains largely unknown.
View Article and Find Full Text PDF